These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9181467)

  • 21. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.
    Hansen BD; Nara PL; Maheshwari RK; Sidhu GS; Bernbaum JG; Hoekzema D; Meltzer MS; Gendelman HE
    J Virol; 1992 Dec; 66(12):7543-8. PubMed ID: 1279206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electron cryotomography studies of maturing HIV-1 particles reveal the assembly pathway of the viral core.
    Woodward CL; Cheng SN; Jensen GJ
    J Virol; 2015 Jan; 89(2):1267-77. PubMed ID: 25392219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of IFN alpha on late stages of HIV-1 replication cycle.
    Dianzani F; Castilletti C; Gentile M; Gelderblom HR; Frezza F; Capobianchi MR
    Biochimie; 1998; 80(8-9):745-54. PubMed ID: 9865497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and infectivity.
    Abdurahman S; Végvári A; Youssefi M; Levi M; Höglund S; Andersson E; Horal P; Svennerholm B; Balzarini J; Vahlne A
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3737-44. PubMed ID: 18644965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the assembly of the human immunodeficiency virus type I.
    Muriaux D; Darlix JL; Cimarelli A
    Curr Pharm Des; 2004; 10(30):3725-39. PubMed ID: 15579067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions.
    Sokolskaja E; Olivari S; Zufferey M; Strambio-De-Castillia C; Pizzato M; Luban J
    J Virol; 2010 May; 84(9):4851-5. PubMed ID: 20181694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-acting stapled peptides target both HIV-1 entry and assembly.
    Zhang H; Curreli F; Waheed AA; Mercredi PY; Mehta M; Bhargava P; Scacalossi D; Tong X; Lee S; Cooper A; Summers MF; Freed EO; Debnath AK
    Retrovirology; 2013 Nov; 10():136. PubMed ID: 24237936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
    Thenin-Houssier S; Valente ST
    Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with HIV-1 capsids and virions.
    Leung K; Kim JO; Ganesh L; Kabat J; Schwartz O; Nabel GJ
    Cell Host Microbe; 2008 May; 3(5):285-92. PubMed ID: 18474355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
    Smith MS; Thresher RJ; Pagano JS
    Antimicrob Agents Chemother; 1991 Jan; 35(1):62-7. PubMed ID: 1707604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.
    Dafonseca S; Coric P; Gay B; Hong SS; Bouaziz S; Boulanger P
    Virol J; 2008 Dec; 5():162. PubMed ID: 19105849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral inhibition of the HIV-1 capsid protein.
    Tang C; Loeliger E; Kinde I; Kyere S; Mayo K; Barklis E; Sun Y; Huang M; Summers MF
    J Mol Biol; 2003 Apr; 327(5):1013-20. PubMed ID: 12662926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes.
    Baca-Regen L; Heinzinger N; Stevenson M; Gendelman HE
    J Virol; 1994 Nov; 68(11):7559-65. PubMed ID: 7933143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PF74 and Its Novel Derivatives Stabilize Hexameric Lattice of HIV-1 Mature-Like Particles.
    Dostálková A; Škach K; Kaufman F; Křížová I; Hadravová R; Flegel M; Ruml T; Hrabal R; Rumlová M
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32325987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts.
    Feng X; Heyden NV; Ratner L
    J Virol; 2003 Dec; 77(24):13389-95. PubMed ID: 14645593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targets of a protease inhibitor, KNI-272, in HIV-1-infected cells.
    Goto T; Nakano T; Kohno T; Morimatsu S; Morita C; Hong W; Kiso Y; Nakai M; Sano K
    J Med Virol; 2001 Mar; 63(3):203-9. PubMed ID: 11170058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells.
    Lambert DM; Petteway SR; McDanal CE; Hart TK; Leary JJ; Dreyer GB; Meek TD; Bugelski PJ; Bolognesi DP; Metcalf BW
    Antimicrob Agents Chemother; 1992 May; 36(5):982-8. PubMed ID: 1510424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAITH - Fast Assembly Inhibitor Test for HIV.
    Hadravová R; Rumlová M; Ruml T
    Virology; 2015 Dec; 486():78-87. PubMed ID: 26410239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-alpha treatment leads to accumulation of virus particles on the surface of cells persistently infected with the human immunodeficiency virus type 1.
    Yasuda Y; Miyake S; Kato S; Kita M; Kishida T; Kimura T; Ikuta K
    J Acquir Immune Defic Syndr (1988); 1990; 3(11):1046-51. PubMed ID: 2213506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.